ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 8 filers reported holding ESSA PHARMA INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $46,017,788 | -38.0% | 8,748,629 | 0.0% | 1.29% | -36.8% |
| Q1 2024 | $74,275,860 | +28.6% | 8,748,629 | 0.0% | 2.04% | +41.3% |
| Q4 2023 | $57,740,951 | +113.6% | 8,748,629 | 0.0% | 1.44% | +98.2% |
| Q3 2023 | $27,033,264 | +14.4% | 8,748,629 | 0.0% | 0.73% | +10.8% |
| Q2 2023 | $23,621,298 | -9.1% | 8,748,629 | 0.0% | 0.66% | -30.7% |
| Q1 2023 | $25,983,428 | +17.9% | 8,748,629 | 0.0% | 0.95% | +2.2% |
| Q4 2022 | $22,046,545 | +38.5% | 8,748,629 | 0.0% | 0.93% | +41.3% |
| Q3 2022 | $15,923,000 | +36.7% | 8,748,629 | +136.5% | 0.66% | +16.9% |
| Q2 2022 | $11,651,000 | -49.0% | 3,698,629 | +0.1% | 0.56% | -38.4% |
| Q1 2022 | $22,839,000 | -43.6% | 3,695,629 | +29.6% | 0.91% | -37.8% |
| Q4 2021 | $40,491,000 | +77.5% | 2,851,461 | 0.0% | 1.47% | +65.2% |
| Q3 2021 | $22,812,000 | -67.4% | 2,851,461 | +16.3% | 0.89% | -66.1% |
| Q2 2021 | $70,041,000 | -17.1% | 2,451,561 | -15.7% | 2.62% | -17.1% |
| Q1 2021 | $84,487,000 | +91.1% | 2,908,326 | -21.5% | 3.17% | +82.2% |
| Q4 2020 | $44,204,000 | +113.1% | 3,705,289 | +23.3% | 1.74% | +53.9% |
| Q3 2020 | $20,739,000 | +68.5% | 3,005,589 | +51.4% | 1.13% | +48.9% |
| Q2 2020 | $12,306,000 | +27.1% | 1,984,889 | -18.0% | 0.76% | -15.9% |
| Q1 2020 | $9,682,000 | -33.3% | 2,420,565 | -8.3% | 0.90% | -18.1% |
| Q4 2019 | $14,523,000 | +63.2% | 2,640,565 | 0.0% | 1.10% | +17.8% |
| Q3 2019 | $8,899,000 | +188.5% | 2,640,565 | +98.6% | 0.94% | +177.4% |
| Q2 2019 | $3,085,000 | +54.9% | 1,329,700 | +129.1% | 0.34% | +51.1% |
| Q1 2019 | $1,991,000 | +63.3% | 580,368 | 0.0% | 0.22% | +40.3% |
| Q4 2018 | $1,219,000 | -29.6% | 580,368 | +0.6% | 0.16% | +4.6% |
| Q3 2018 | $1,731,000 | -17.2% | 576,771 | +4.3% | 0.15% | -25.5% |
| Q2 2018 | $2,090,000 | – | 552,791 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 3,525,457 | $50,061,000 | 5.01% |
| MPM BioImpact LLC | 668,688 | $9,495,000 | 1.73% |
| BVF INC/IL | 2,851,461 | $40,491,000 | 1.47% |
| Altium Capital Management LP | 345,000 | $4,899,000 | 1.35% |
| Logos Global Management LP | 865,000 | $12,283,000 | 1.27% |
| Lynwood Capital Management Inc. | 57,181 | $812,000 | 0.78% |
| Avidity Partners Management LP | 2,460,000 | $34,932,000 | 0.74% |
| Bellevue Group AG | 5,034,814 | $71,495,000 | 0.74% |
| SPHERA FUNDS MANAGEMENT LTD. | 422,461 | $5,999,000 | 0.66% |
| Omega Fund Management, LLC | 328,196 | $4,660,000 | 0.66% |